Back to results
Not yet recruitingPhase 2Phase 3

A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Transcranial Magnetic Stimulation for Treatment Resistant Depression

NCT07227103

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Cohen and Associates

Sarasota, Florida, United States

Contact

Rebecca S Cohen, MD

9144049688rcohen@hopetherapeutics.com
View on ClinicalTrials.gov
A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Transcranial Magnetic Stimulation for Treatment Resistant Depression — TrialFind